Comparative analysis of cancer genes in the human and chimpanzee genomes.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 1382208)

Published in BMC Genomics on January 26, 2006

Authors

Xose S Puente1, Gloria Velasco, Ana Gutiérrez-Fernández, Jaume Bertranpetit, Mary-Claire King, Carlos López-Otín

Author Affiliations

1: Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, 33006-Oviedo, Spain. xspuente@uniovi.es

Articles citing this

Inferring noncoding RNA families and classes by means of genome-scale structure-based clustering. PLoS Comput Biol (2007) 4.28

p53 polymorphisms: cancer implications. Nat Rev Cancer (2009) 3.33

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer. Nat Med (2011) 2.49

Evolution in health and medicine Sackler colloquium: Evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition. Proc Natl Acad Sci U S A (2009) 1.79

Alu recombination-mediated structural deletions in the chimpanzee genome. PLoS Genet (2007) 1.59

The role of positive selection in determining the molecular cause of species differences in disease. BMC Evol Biol (2008) 1.11

Systematic reviews of animal models: methodology versus epistemology. Int J Med Sci (2013) 1.01

Biological Differences in rAAV Transduction of Airway Epithelia in Humans and in Old World Non-human Primates. Mol Ther (2007) 0.96

A comparative approach shows differences in patterns of numt insertion during hominoid evolution. J Mol Evol (2009) 0.96

The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. Cell Rep (2016) 0.96

NANOGP8: evolution of a human-specific retro-oncogene. G3 (Bethesda) (2012) 0.86

Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations. BMC Cancer (2015) 0.82

On the apparent rarity of epithelial cancers in captive chimpanzees. Philos Trans R Soc Lond B Biol Sci (2015) 0.80

Canine cancer immunotherapy studies: linking mouse and human. J Immunother Cancer (2016) 0.77

Spontaneous leiomyomas of the gastroesophageal junction in a chimpanzee (Pan troglodytes). Comp Med (2014) 0.76

The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases. Meta Gene (2013) 0.76

An exon-based comparative variant analysis pipeline to study the scale and role of frameshift and nonsense mutation in the human-chimpanzee divergence. Comp Funct Genomics (2009) 0.76

Malignant Neoplasia of the Sex Skin in 2 Chimpanzees (Pan troglodytes). Comp Med (2016) 0.75

Adaptive Evolution Coupled with Retrotransposon Exaptation Allowed for the Generation of a Human-Protein-Specific Coding Gene That Promotes Cancer Cell Proliferation and Metastasis in Both Haematological Malignancies and Solid Tumours: The Extraordinary Case of MYEOV Gene. Scientifica (Cairo) (2015) 0.75

TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development. World J Gastroenterol (2015) 0.75

Selective targeting p53(WT) lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA. Oncogene (2017) 0.75

Articles cited by this

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31

BLAT--the BLAST-like alignment tool. Genome Res (2002) 126.78

The hallmarks of cancer. Cell (2000) 113.05

The International HapMap Project. Nature (2003) 73.65

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med (2004) 71.08

Inflammation and cancer. Nature (2002) 53.78

A census of human cancer genes. Nat Rev Cancer (2004) 36.20

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med (2001) 24.51

Cancer genes and the pathways they control. Nat Med (2004) 24.22

Evolution at two levels in humans and chimpanzees. Science (1975) 21.07

The DNA damage response: putting checkpoints in perspective. Nature (2000) 19.07

The history of cancer epigenetics. Nat Rev Cancer (2004) 14.38

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science (2003) 13.19

Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat (2003) 12.88

Cancer and the chemokine network. Nat Rev Cancer (2004) 10.27

Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res (2002) 9.50

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell (2004) 8.18

Intra- and interspecific variation in primate gene expression patterns. Science (2002) 7.92

The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet (2003) 6.46

Dissecting the metastatic cascade. Nat Rev Cancer (2004) 6.32

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature (1998) 6.16

Inactivation of hCDC4 can cause chromosomal instability. Nature (2004) 5.71

Modelling the molecular circuitry of cancer. Nat Rev Cancer (2002) 5.43

The proteasome: a suitable antineoplastic target. Nat Rev Cancer (2004) 5.22

Connecting chromosomes, crisis, and cancer. Science (2002) 4.69

Elevated gene expression levels distinguish human from non-human primate brains. Proc Natl Acad Sci U S A (2003) 4.69

Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science (2004) 4.67

Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst (2000) 4.03

Regional patterns of gene expression in human and chimpanzee brains. Genome Res (2004) 3.84

Inflammation and necrosis promote tumour growth. Nat Rev Immunol (2004) 3.68

Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol (1987) 3.22

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet (2000) 2.69

Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet (2003) 2.69

Three classes of genes mutated in colorectal cancers with chromosomal instability. Cancer Res (2004) 2.51

Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees. Australian Breast Cancer Family Study. Nat Genet (2000) 2.43

The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer (2004) 2.38

Diet and cancer--the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer (2004) 2.24

Is p53 polymorphism maintained by natural selection? Hum Hered (1994) 1.92

A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet (2000) 1.80

Targeted therapy in breast cancer: the HER-2/neu gene and protein. Mol Cell Proteomics (2004) 1.76

The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci (2000) 1.71

Alterations of pre-mRNA splicing in cancer. Genes Chromosomes Cancer (2005) 1.70

Meat-adaptive genes and the evolution of slower aging in humans. Q Rev Biol (2004) 1.67

Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res (2004) 1.60

Understanding missense mutations in the BRCA1 gene: an evolutionary approach. Proc Natl Acad Sci U S A (2003) 1.55

A chimpanzee genome project is a biomedical imperative. Genome Res (2000) 1.48

Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer (2004) 1.43

Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms. Proc Natl Acad Sci U S A (2004) 1.36

Chemical-induced DNA damage and human cancer risk. Nat Rev Cancer (2004) 1.34

p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev (2004) 1.26

Differences in DNA methylation patterns between humans and chimpanzees. Curr Biol (2004) 1.24

Neoplasms and proliferative lesions in 1065 nonhuman primate necropsies. Lab Anim Sci (1973) 1.23

Have environmental mutagens caused oncomutations in people? Nat Genet (2003) 1.17

An overview of the world literature on spontaneous tumors in nonhuman primates. J Med Primatol (1989) 1.17

Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition. Hum Mol Genet (2004) 1.17

Genetic testing for cancer susceptibility: the promise and the pitfalls. Nat Rev Cancer (2004) 1.16

Tumors in nonhuman primates: observations during a six-year period in the Yerkes primate center colony. Am J Phys Anthropol (1973) 1.14

The chimpanzee model of hepatitis C virus infections. ILAR J (2001) 1.13

Similarities of prostate and breast cancer: Evolution, diet, and estrogens. Urology (2001) 1.10

Comparative genomic analysis of human and chimpanzee proteases. Genomics (2005) 1.01

Evolutionary dynamics of oncogenes and tumor suppressor genes: higher intensities of purifying selection than other genes. Mol Biol Evol (2003) 1.01

Workgroup 4: spontaneous prostate carcinoma in dogs and nonhuman primates. Prostate (1998) 1.00

Diversifying selection of the tumor-growth promoter angiogenin in primate evolution. Mol Biol Evol (2002) 0.96

Brca1 expression is regulated by a bidirectional promoter that is shared by the Nbr1 gene in mouse. Gene (2004) 0.82

The ink4a/arf locus evolution in primates: characterization of three ARF sequences. DNA Cell Biol (2004) 0.79

Comparative genetics of functional trinucleotide tandem repeats in humans and apes. J Mol Evol (2004) 0.78

Articles by these authors

Strong association of de novo copy number mutations with autism. Science (2007) 27.84

Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature (2004) 24.40

Signatures of mutational processes in human cancer. Nature (2013) 21.63

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92

Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science (2008) 20.68

International network of cancer genome projects. Nature (2010) 20.35

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature (2011) 13.18

Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med (2008) 10.88

Genetic heterogeneity in human disease. Cell (2010) 10.67

Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry (2007) 7.00

A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet (2010) 6.62

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet (2011) 6.43

Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet (2009) 6.13

The genome of a songbird. Nature (2010) 5.90

Genome analysis of the platypus reveals unique signatures of evolution. Nature (2008) 5.74

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci U S A (2010) 5.60

Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer (2002) 5.57

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA (2006) 5.51

Correlation between genetic and geographic structure in Europe. Curr Biol (2008) 5.02

Breast-cancer risk in families with mutations in PALB2. N Engl J Med (2014) 4.97

Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82. Am J Hum Genet (2010) 4.95

Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med (2014) 4.70

Genomic instability in laminopathy-based premature aging. Nat Med (2005) 4.54

An immunosurveillance mechanism controls cancer cell ploidy. Science (2012) 4.35

Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J Biol Chem (2007) 4.22

Human and mouse proteases: a comparative genomic approach. Nat Rev Genet (2003) 4.02

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci U S A (2011) 3.99

Comparative and demographic analysis of orang-utan genomes. Nature (2011) 3.83

Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet (2002) 3.78

The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell (2010) 3.64

The dawn of human matrilineal diversity. Am J Hum Genet (2008) 3.60

Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell (2012) 3.54

Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature (2011) 3.51

Ten genes for inherited breast cancer. Cancer Cell (2007) 3.45

The derived FOXP2 variant of modern humans was shared with Neandertals. Curr Biol (2007) 3.39

Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat Med (2008) 3.34

Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature (2005) 3.31

Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci U S A (2004) 3.27

Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell (2013) 3.26

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin Cancer Res (2013) 3.25

The origin of European cattle: evidence from modern and ancient DNA. Proc Natl Acad Sci U S A (2006) 3.09

Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet (2012) 3.08

Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05

Great ape genetic diversity and population history. Nature (2013) 2.95

Medicine. The future of psychiatric research: genomes and neural circuits. Science (2010) 2.79

Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault Syndrome. Am J Hum Genet (2010) 2.76

Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood (2008) 2.75

Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet (2003) 2.69

Genomic affinities of two 7,000-year-old Iberian hunter-gatherers. Curr Biol (2012) 2.67

POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat Genet (2013) 2.62

Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol (2011) 2.62

A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet (2002) 2.60

DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc Natl Acad Sci U S A (2002) 2.58

Genomic ancestry of North Africans supports back-to-Africa migrations. PLoS Genet (2012) 2.51

Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem (2002) 2.31

Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer Res (2011) 2.27

Evidence for a genetic discontinuity between Neandertals and 24,000-year-old anatomically modern Europeans. Proc Natl Acad Sci U S A (2003) 2.25

Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science (2013) 2.24

Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J Cell Biol (2011) 2.23

Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol (2004) 2.23

Accurate and exact CNV identification from targeted high-throughput sequence data. BMC Genomics (2011) 2.20

From flies' eyes to our ears: mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30. Proc Natl Acad Sci U S A (2002) 2.17

A melanocortin 1 receptor allele suggests varying pigmentation among Neanderthals. Science (2007) 2.15

Human autophagins, a family of cysteine proteinases potentially implicated in cell degradation by autophagy. J Biol Chem (2002) 2.15

Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. Biochem Biophys Res Commun (2004) 2.13

Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc Natl Acad Sci U S A (2011) 2.11

Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors. Hum Mol Genet (2005) 2.06

Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains. Gene (2002) 2.05

LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PLoS One (2007) 2.01

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci U S A (2013) 2.00

ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing. J Mol Diagn (2012) 1.99

The portability of tagSNPs across populations: a worldwide survey. Genome Res (2006) 1.99

Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A (2006) 1.99

BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci U S A (2002) 1.89

Autophagy is essential for mouse sense of balance. J Clin Invest (2010) 1.81

Nuclear gene indicates coat-color polymorphism in mammoths. Science (2006) 1.77

Gene flow from North Africa contributes to differential human genetic diversity in southern Europe. Proc Natl Acad Sci U S A (2013) 1.77

Y-chromosomal diversity in Lebanon is structured by recent historical events. Am J Hum Genet (2008) 1.75

Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J (2007) 1.74

Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta (2009) 1.73

Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer. Am J Obstet Gynecol (2005) 1.72

A role of matrix metalloproteinase-8 in atherosclerosis. Circ Res (2009) 1.72

Mitochondrial DNA of an Iberian Neandertal suggests a population affinity with other European Neandertals. Curr Biol (2006) 1.69

Five novel loci for inherited hearing loss mapped by SNP-based homozygosity profiles in Palestinian families. Eur J Hum Genet (2009) 1.67

Balancing selection is the main force shaping the evolution of innate immunity genes. J Immunol (2008) 1.63

Tracking down human contamination in ancient human teeth. Mol Biol Evol (2006) 1.61

Matrix metalloproteinases and tumor progression. Adv Exp Med Biol (2003) 1.61

A highly divergent mtDNA sequence in a Neandertal individual from Italy. Curr Biol (2006) 1.59

Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice. EMBO J (2012) 1.58

Matrix metalloproteinase-19 expression in dermal wounds and by fibroblasts in culture. J Invest Dermatol (2003) 1.57

Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Cancer Res (2008) 1.57

Genomic analysis of mental illness: a changing landscape. JAMA (2010) 1.56